Morepen Executive and Leadership Team

Sanjay Suri, the Executive Director and Chief Executive Officer of API Division at Morepen, directs the strategic production of Active Pharmaceutical Ingredients. Overseeing complex chemical synthesis and regulatory compliance, the Chief Executive Officer of API Division ensures adherence to USFDA and WHO GMP standards across all manufacturing facilities. This leadership role involves optimizing supply chain efficiency to support global pharmaceutical demand. By driving innovation in API development, Sanjay Suri strengthens the competitive position of the company within the international market. The Chief Executive Officer of API Division maintains close collaboration with the Board to align production capacity with long-term growth objectives. Through meticulous oversight of technical operations, the executive guarantees product excellence. Ultimately, Suri secures the foundational manufacturing capabilities required for the continued expansion of the pharmaceutical portfolio.

Varun Suri, the Chief Executive Officer, Consumer Business at Morepen, manages the growth of the Dr. Morepen and Gubb World brands. Directing product development and market penetration, the Chief Executive Officer, Consumer Business executes strategies to reach over 100 million consumers. This role involves analyzing market trends to expand the reach of OTC and grooming products across diverse retail channels. By fostering brand loyalty, Varun Suri drives revenue growth and enhances the visibility of the consumer portfolio. The Chief Executive Officer, Consumer Business coordinates with marketing teams to ensure consistent messaging and product availability. Through strategic planning, the executive scales operations to meet rising demand for wellness solutions. Ultimately, Suri positions the consumer division as a primary driver of the overall corporate mission to improve daily health outcomes.

Amita Sharma, the Chief Operating Officer at Morepen, manages internal processes and manufacturing efficiency to support the company's pharmaceutical output. Overseeing daily operations, the Chief Operating Officer ensures that production workflows align with quality standards and safety protocols. This leadership role involves streamlining logistics and resource allocation to maintain high productivity levels across all facilities. By implementing lean manufacturing principles, Amita Sharma reduces operational costs and improves delivery timelines. The Chief Operating Officer coordinates with department heads to resolve bottlenecks and enhance cross-functional collaboration. Through rigorous monitoring of performance metrics, the executive maintains operational excellence. Ultimately, Sharma supports the company's growth by ensuring that internal systems remain scalable and responsive to the evolving needs of the global pharmaceutical market.

Kushal Suri, the President, International Growth at Morepen, directs the expansion of the company's footprint across more than 80 countries. Overseeing global market entry and partnership development, the President, International Growth identifies new opportunities for exporting APIs and finished formulations. This leadership role involves navigating complex international regulatory landscapes to ensure seamless product distribution. By building relationships with global distributors, Kushal Suri drives the international revenue stream. The President, International Growth collaborates with the executive team to tailor product offerings to specific regional needs. Through strategic market analysis, the executive identifies high-growth territories for future investment. Ultimately, Suri strengthens the global presence of the company, ensuring that high-quality healthcare solutions reach diverse populations across the world while maintaining strict adherence to international quality standards.

Tj Anthony, the President, Generics, OTC & Business Development (US) at Morepen, leads the strategic initiatives for the North American market. Overseeing the development of generic pharmaceutical products and OTC offerings, the President, Generics, OTC & Business Development (US) ensures that the company meets the specific demands of the US healthcare system. This leadership role involves managing business development activities to secure new partnerships and market share. By focusing on regulatory compliance and product quality, Tj Anthony drives the success of the generics portfolio. The President, Generics, OTC & Business Development (US) coordinates with the R&D team to align product pipelines with market gaps. Through proactive engagement with industry stakeholders, the executive expands the reach of the company in the competitive US landscape. Ultimately, Anthony secures long-term growth by delivering reliable and affordable healthcare solutions.

Priti Mahwar, the Chief Marketing Officer at Morepen, architects the brand identity and promotional strategies for the entire product range. Overseeing digital campaigns and traditional advertising, the Chief Marketing Officer ensures effective communication of the value proposition to a vast consumer base. This leadership role involves managing brand equity for Dr. Morepen and Gubb World to maintain market relevance. By analyzing consumer behavior, Priti Mahwar optimizes marketing spend to maximize return on investment. The Chief Marketing Officer collaborates with the sales and product teams to launch new healthcare solutions successfully. Through creative storytelling and data-driven insights, the executive builds strong connections with the target audience. Ultimately, Mahwar elevates the market presence of the company, ensuring that the brand remains a trusted name in the pharmaceutical and grooming sectors.